Agios Pharmaceuticals (AGIO) Return on Invested Capital (2013 - 2025)

Agios Pharmaceuticals has reported Return on Invested Capital for 6 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.0% in Q4 2024, with the low at 0.0% in Q4 2023.
• Historically, Return on Invested Capital has averaged 0.0% across 3 years, with a median of 0.0% in 2023.
• The largest YoY upside for Return on Invested Capital was 0 bps in 2024 against a maximum downside of 0 bps in 2024.
• Agios Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2023, then jumped by 45 bps to 0.0% in 2024, then plunged by 67 bps to 0.0% in 2025.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q4 2024), per Business Quant data.